Clinical trial
Efficacy and Safety of Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly Cirrhotic Patients: a Real Life Study
NCT02702739 is registered in ClinicalTrials.gov with Azienda Ospedaliera San Camillo Forlanini as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly Cirrhotic Patients: a Real Life Study
- Lead sponsor
- Azienda Ospedaliera San Camillo Forlanini
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- February 29, 2016
- Enrollment
- 270 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.